Browse > Article
http://dx.doi.org/10.4070/kcj.2010.40.8.357

Magnetic Resonance Imaging Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia in Children  

Yoo, Shi-Joon (Department of Diagnostic Imaging, The Hospital for Sick Children and Research Institute, University of Toronto)
Grosse-Wortmann, Lars (Department of Diagnostic Imaging, The Hospital for Sick Children and Research Institute, University of Toronto)
Hamilton, Robert M. (Department of the Labatt Heart Centre, The Hospital for Sick Children and Research Institute, University of Toronto)
Publication Information
Korean Circulation Journal / v.40, no.8, 2010 , pp. 357-367 More about this Journal
Abstract
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetically determined disease that progresses continuously from conception and throughout life. ARVC/D manifests predominantly in young adulthood. Early identification of the concealed cases in childhood is of utmost importance for the prevention of sudden cardiac death later in life. Magnetic resonance imaging (MRI) is routinely requested in patients with a confirmed or suspected diagnosis of ARVC/D and in family members of the patients with ARVC/D. Although the utility of MRI in the assessment of ARVC/D is well recognized in adults, MRI is a low-yield test in children as the anatomical, histological, and functional changes are frequently subtle or not present in the early phase of the disease. MRI findings of ARVC/D include morphologic changes such as right ventricular dilatation, wall thinning, and aneurismal outpouchings, as well as abnormal tissue characteristics such as myocardial fibrosis and fatty infiltration, and functional abnormalities such as global ventricular dysfunction and regional wall motion abnormalities. Among these findings, regional wall motion abnormalities are the most reliable MRI findings both in children and adults, while myocardial fibrosis and fat infiltration are rarely seen in children. Therefore, an MRI protocol should be tailored according to the patient's age and compliance, as well as the presence of other findings, instead of using the protocol that is used for adults. We propose that MRI in children with ARVC/D should focus on the detection of regional wall motion abnormalities and global ventricular function by using a cine imaging sequence and that the sequences for myocardial fat and late gadolinium enhancement of the myocardium are reserved for those who show abnormal findings at cine imaging. Importantly, MRI should be performed and interpreted by experienced examiners to reduce the number of false positive and false negative readings.
Keywords
Arrhythmogenic right ventricular cardiomyopathy/dysplasia; Children; Magnetic resonance imaging;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 2006;48:2132-40.   DOI   ScienceOn
2 Grosse-Wortmann L, Macgowan CK, Vidarsson L, Yoo SJ. Late gadolinium enhancement of the right ventricular myocardium: is it really different from the left? J Cardiovasc Magn Reson 2008;10:20.   DOI
3 Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmognic right ventricular dysplasia. AJR Am J Roentgenol 1994;162:809-12.   DOI   ScienceOn
4 Molinari G, Sardanelli F, Gaita F, et al. Right ventricular dysplasia as a generalized cardiomyopathy?: findings on magnetic resonance imaging. Eur Heart J 1995;16:1619-24.   DOI
5 Kayser HW, van der Wall EE, Sivananthan MU, Plein S, Bloomer TN, de Roos A. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 2002;22:639-48.   DOI
6 Castillo E, Tandri H, Rodriguez ER, et al. Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology 2004;232:38-48.   DOI   ScienceOn
7 Bluemke DA, Krupinski EA, Ovitt T, et al. MR imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003;99:153-62.   DOI   ScienceOn
8 Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277-84.   DOI   ScienceOn
9 Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998;97:1571-80.   DOI   ScienceOn
10 Tandri H, Macedo R, Calkins H, et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J 2008;155:147-53.   DOI   ScienceOn
11 Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103.   DOI   ScienceOn
12 Dalal D, Tandri H, Judge DP, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy: a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol 2009;53:1289-99.   DOI   ScienceOn
13 Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular disease: MR imaging vs. angiography. AJR Am J Roentgenol 1993;161:549-55.   DOI   ScienceOn
14 Tandri H, Calkins H, Nasir K, et al. Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2003;14:476-82.   DOI   ScienceOn
15 Groenink M, Wilde AA. The "accordion sign" a new tune in arrhythmogenic right ventricular dysplasia/cardiomyopathy magnetic resonance imaging? J Am Coll Cardiol 2009;53:1300-1.   DOI   ScienceOn
16 Ricci C, Longo R, Pagnan L, et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589-95.   DOI   ScienceOn
17 Marcus FI, Zareba W, Calkins H, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 2009;6:984-92.   DOI   ScienceOn
18 McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.   DOI
19 Asimaki A, Tandri H, Huang H, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009;360:1075-84.   DOI   ScienceOn
20 Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation 2010;121:1533-41. Eur Heart J 2010;31:806-14.   DOI   ScienceOn
21 Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004;110:1879-84.   DOI   ScienceOn
22 Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-59.   DOI   ScienceOn
23 Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010;61:233-53.   DOI   ScienceOn
24 Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.   DOI   ScienceOn
25 Thiene G, Carturan E, Corrado D, Basso C. Prevention of sudden cardiac death in the young and in athletes: dream or reality? Cardiovasc Pathol 2009. [Epub ahead of print]
26 Basso C, Corrado D, Marcus RI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009;373:1289-300.   DOI   ScienceOn
27 Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007;50:1813-21.   DOI   ScienceOn
28 Corrado D, Basso C, Thine G. Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009;95:766-73.   DOI   ScienceOn
29 Hamilton RM, Fidler L. Right ventricular cardiomyopathy in the young: an emerging challenge. Heart Rhythm 2009;6:571-5.   DOI   ScienceOn
30 Saffitz JE. Desmosome mutations in arrhythmogenic right ventricular cardiomyopathy: important insight but only part of the future. Circ Cardiovasc Genet 2009;2:415-7.   DOI   ScienceOn
31 Bhuiyan ZA, Jonboed JD, van der Smagt J, et al. Desmoglein-2 and desmocollin-2 mutations in Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy patients: result from a multicenter study. Circ Cardiovasc Genet 2009;2:418-27.   DOI   ScienceOn
32 den Haan AD, Tan BY, Zikusoka MN, et al. Comprehensive desmosome mutation analysis in north Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet 2009;2:428-35.   DOI
33 Hershberger RE, Cowan J, Morales A, Sigfried JD. Screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009;2:253-61.   DOI   ScienceOn
34 Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007;115:1710-20.   DOI   ScienceOn
35 Turrini P, Corrado D, Basso C, Nava A, Thiene G. Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 2003;8:161-9.   DOI
36 Sen-Chowdhry S, McKenna WJ. The utility of magnetic resonance imaging in the evaluation of arrhtymogenic right ventricular cardiomyopathy. Curr Opin Cardiol 2008;23:38-45.   DOI   ScienceOn
37 Tabib A, Loire R, Chalabreysse L, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-5.   DOI   ScienceOn
38 Aviram G, Fishman JE, Young ML, Redha E, Biliciler-Denktas G, Rodriguez MM. MR evaluation of arrhythmogenic right ventricular cardiomyopathy in pediatric patients. AJR Am J Roentgenol 2003;180:1135-41.   DOI   ScienceOn
39 Hamdan A, Thouet T, Sebastian K, et al. Regional right ventricular function and timing of contraction in healthy volunteers evaluated by strain-encoded MRI. J Magn Reson Imaging 2008;28:1379-85.   DOI   ScienceOn
40 Jain A, Shehata ML, Stuber M, et al. Prevalence of left ventricular regional dysfunction in arrhythmogenic right ventricular dysplasia: a tagged MRI study. Circ Cardiovasc Imaging 2010;3:290-7.   DOI   ScienceOn
41 Hunold P, Wieneke H, Bruder O, et al. Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy? J Cardiovasc Magn Reson 2005;7:649-55.   DOI
42 Fogel MA, Weinberg PM, Harris M, Rhodes L. Usefulness of magnetic resonance imaging for the diagnosis of right ventricular dysplasia in children. Am J Cardiol 2006;97:1232-7.   DOI   ScienceOn
43 Fontaine G, Fontaliran F, Zenati O, et al. Fat in the heart: a feature unique to the human species? Observational reflections on an unsolved problem. Acta Cardiol 1999;54:189-94.
44 Macedo R, Prakasa K, Tichnell C, et al. Marked lipomatous infiltration of the right ventricle: MRI findings in relation to arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 2007;188:W423-7.   DOI